LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

ABSTRACT: RATIONALE: The LMB-9 immunotoxin may be able to locate tumor cells and kill them without harming normal cells. This may be an effective treatment for advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of LMB-9 immunotoxin in treating patients who have advanced solid tumors that have not responded to standard therapy.

DISEASE(S): Lung Cancer,Colorectal Cancer,Bladder Cancer,Urinary Bladder Neoplasms,Pancreatic Cancer,Breast Neoplasms,Breast Cancer,Lung Neoplasms,Esophageal Neoplasms,Gastric Cancer,Esophageal Cancer,Pancreatic Neoplasms,Stomach Neoplasms

PROVIDER: 2006394 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR